logo

For the Inventor, By the Inventor

Ibaraki, Japan

Toshio Goto

This inventor holds 17 USPTO granted patents, plus 1 CIPO patent, primarily in Tricyclo Compounds. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1990-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshio Goto. Retrieved from https://idiyas.com/inventor/toshio-goto-v5pjh0v2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 100.0


Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 318(Granted Patents)


Location History:

  • Tsukuba, JP (1990)
  • Sakuramura, JP (1992 - 1993)
  • Kobe, JP (1995 - 1996)
  • Niihari, JP (1996)
  • Niihari-gun, JP (1997 - 2000)
  • Ibaraki, JP (1990 - 2002)

Company Filing History:

goldMedal17 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1990-2002

Loading Chart...
Loading Chart...
Areas of Expertise:
Interleukin-2
Immunosuppression
Lymphokine
Streptomyces
Cyclosporin A
Antitumor Activity
Production Process
Pharmaceutical
Amino Acid Derivatives
WB2663 Substances
FR901228
Tricyclo Compounds
17 patents (USPTO):Explore Patents
1. 6482845 - Method for inhibiting interleukin-2 production using tricyclo compounds (2002-11-19),
2. 6201005 - Method for inhibiting lymphokine production (2001-03-13),
3. 6028097 - Method of immunosuppression (2000-02-22),
4. 5830717 - Process for production of tricyclo compounds with streptomyces (1998-11-03),
5. 5624842 - Strain of Streptomyces for the production of tricyclo compounds (1997-04-29),
6. 5565559 - Tricyclo compounds, a process for their production and a pharmaceutical (1996-10-15),
7. 5545542 - WB2663 substances and method for their production (1996-08-13),
8. 5496727 - Tricyclo compounds, a process for their production and a pharmaceutical (1996-03-05),
9. 5447854 - Production of cyclosporin A and/or C with a strain of NECTRIA (1995-09-05),
10. 5266692 - Tricyclo compounds, a process for their production and a pharmaceutical (1993-11-30),
11. 5254562 - Tricyclo compounds, a process for their production and a pharmaceutical (1993-10-19),
12. 5110811 - Tricyclo compounds, a process for their production and a pharmaceutical (1992-05-05),
13. 4977138 - FR901228 substance and preparation thereof (1990-12-11),
14. 4956352 - Tricyclo compounds, a process for their production and a pharmaceutical (1990-09-11),
15. 4939241 - Amino acid derivatives of antitumor activity (1990-07-03),

Title: The Innovative Contributions of Toshio Goto

Introduction

Toshio Goto is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. With a total of 17 patents to his name, Goto's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents are methods for inhibiting interleukin-2 production using tricyclo compounds and methods for inhibiting lymphokine production. These inventions relate to tricyclo compounds that are useful for the treatment and prevention of resistance in transplantation, graft-versus-host diseases, autoimmune diseases, and infectious diseases.

Career Highlights

Toshio Goto is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His innovative approaches have led to breakthroughs in the treatment of various medical conditions.

Collaborations

Throughout his career, Goto has collaborated with notable colleagues, including Masakuni Okuhara and Hirokazu Tanaka. These partnerships have fostered a collaborative environment that enhances the potential for innovation in their field.

Conclusion

Toshio Goto's contributions to pharmaceutical science through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…